Table 1.
Selection of technologies developed during the first phase of tchia-he 4DN Program and the number of citations found using the NIH iCite (https://icite.od.nih.gov) tool (Hutchins, Yuan, Anderson, & Santangelo, 2016)50.
| Technology | Reference | Citations |
|---|---|---|
| CUT&Tag | (Kaya-Okur, et al., 2019)26 | 489 |
| ChromEMT | (Ou, et al., 2017)31 | 418 |
| sn-Hi-C | (Flyamer, et al., 2017)22 | 403 |
| OptoDroplet | (Shin, et al., 2017)40 | 377 |
| DNA SPRITE | (Quinodoz, et al., 2018)24 | 376 |
| CRISPRrainbow | (Ma, et al., 2016)32 | 224 |
| PLAC-seq | (Fang, et al., 2016)56 | 167 |
| TSA-seq | (Chen, et al., 2018)57 | 155 |
| Micro-C (in mammalian cells) | (Krietenstein, et al., 2020)58; (Hsieh, et al., 2020)59 | 152; 155 |
| ChIA-Drop | (Zheng, et al., 2019)25 | 103 |
| RNA-DNA SPRITE | (Quinodoz, et al., 2021)60 | 67 |
| C-BERST | (Gao, et al., 2018)61 | 67 |
| NAD-seq | (Vertii, et al., 2019)62 | 41 |
| TrAC-loop | (Lai, et al., 2018)63 | 39 |
| High Resolution Repli-seq | (Zhao, Sasaki, & Gilbert, 2020)64 | 35 |
| Sci-Hi-C | (Ramani, et al., 2020)65 | 34 |
| pa-DamID | (van Schaik, Vos, Peric-Hupkes, Hn Celie, & van Steensel, 2020)66 | 30 |
| Liquid Chromatin Hi-C | (Belaghzal, et al., 2021)67 | 30 |
| immuno-GAM | (Winick-Ng, et al., 2021)20 | 25 |
| Multi-contact 3C | (Tavares-Cadete, Norouzi, Dekker, Liu, & Dekker, 2020)68 | 25 |
| iMARGI | (Wu, et al., 2019)27 | 15 |
| Hi-C 3.0 | (Lafontaine, Yang, Dekker, & Gibcus, 2021)69 | 7 |